Status:
COMPLETED
Accuracy of Half of the Usual Radiotracer Dose in SPECT
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There has been a shortage of nuclear isotopes, not only in Canada but around the world. New, more sensitive SPECT cameras can obtain better images in shorter scan times. These cameras have also shown ...
Detailed Description
SPECT MPI is well accepted as a reliable and cost-effective tool for diagnosis, risk stratification and management of patients with suspected or known coronary artery disease (CAD) (1;2). MPI represen...
Eligibility Criteria
Inclusion
- Consecutive patients presenting for clinically indicated SPECT perfusion scan
- Patients presenting to sites with a functional CZT camera. Available sites are Ottawa (OHI), Mississauga, and Calgary.
- Age \>18 years old
Exclusion
- Patients with a life expectancy less than 1 year, from non cardiac cause
- Age \< 18 years old or lack of consent
- Allergy or contraindication to dipyridamole
- Refractory angina or infarction or need for urgent angiography
- Known pregnancy
- Uncontrolled atrial fibrillation
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01412827
Start Date
April 1 2010
End Date
September 1 2014
Last Update
February 24 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada